Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy
度伐利尤单抗用于根治性放化疗后的III期EGFR突变型非小细胞肺癌
期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2021.01.1628
Aredo, Jacqueline V; Mambetsariev, Isa; Hellyer, Jessica A; Amini, Arya; Neal, Joel W; Padda, Sukhmani K; McCoach, Caroline E; Riess, Jonathan W; Cabebe, Elwyn C; Naidoo, Jarushka; Abuali, Tariq; Salgia, Ravi; Loo, Billy W Jr; Diehn, Maximilian; Han, Summer S; Wakelee, Heather A